These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11099266)

  • 21. The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Peritogiannis V; Tsouli S
    J Clin Psychiatry; 2011 Jul; 72(7):1016; author reply 1016-7. PubMed ID: 21824463
    [No Abstract]   [Full Text] [Related]  

  • 22. Atypical antipsychotics in the treatment of schizophrenia. Validity of dropout rates as proxy measure of tolerability is unknown.
    Rowsell R; Link C; Donoghue J
    BMJ; 2001 Apr; 322(7291):925; author reply 927-8. PubMed ID: 11302917
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical antipsychotics in the treatment of schizophrenia. Paper underrates patients' experience of extrapyramidal symptoms.
    Kerwin R
    BMJ; 2001 Apr; 322(7291):926-7; author reply 927-8. PubMed ID: 11302914
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiovascular risks of atypical antipsychotic drug treatment.
    Drici MD; Priori S
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypomania induced by atypical antipsychotics among schizophrenic patients: report of three cases.
    Baldaçara L; de Castro Ferrari MC; Monteiro BF; Uchida RR; Sanches M
    Pharmacopsychiatry; 2007 Jul; 40(4):169-70. PubMed ID: 17694481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical Antipsychotics for Schizophrenia and/or Bipolar Disorder in Pregnancy: Current Recommendations and Updates in the NICE Guidelines.
    Poo SX; Agius M
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S255-60. PubMed ID: 26417775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
    Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
    Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choosing between atypical antipsychotics: weighing the risks and benefits.
    Bailey KP
    Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S2-S11. PubMed ID: 12046019
    [No Abstract]   [Full Text] [Related]  

  • 30. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifying the risk of atypical antipsychotics in the treatment of juvenile-onset schizophrenia.
    Townsend L; Findling RL
    Expert Opin Pharmacother; 2010 Feb; 11(2):195-205. PubMed ID: 20088741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotics and glycemia: a case report.
    Waldman JC; Yaren S
    Can J Psychiatry; 2002 Sep; 47(7):686-7. PubMed ID: 12355686
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of antipsychotics on brain structure.
    Scherk H; Falkai P
    Curr Opin Psychiatry; 2006 Mar; 19(2):145-50. PubMed ID: 16612194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring for metabolic complications associated with atypical antipsychotics.
    Farver D
    S D J Med; 2005 Feb; 58(2):53-4. PubMed ID: 15756776
    [No Abstract]   [Full Text] [Related]  

  • 36. Switching in the era of atypical antipsychotics. An updated review.
    Weiden PJ
    Postgrad Med; 2006 Sep; Spec No():27-44. PubMed ID: 17128659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research progress of antipsychotics].
    Yang FP; He Y; Wang Z; Wang Y; Jiang XR; Shen JS
    Yao Xue Xue Bao; 2016 Dec; 51(12):1809-21. PubMed ID: 29908532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical antipsychotics: enhancing healthy outcomes.
    Casey DE
    Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S12-9. PubMed ID: 12046020
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of akathisia associated with atypical antipsychotics.
    Agarkar S; Anthony D; Ferrando S
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E46-7. PubMed ID: 23487231
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term treatment with atypical antipsychotics and risk of weight gain.
    Stip E; Anselmo K; Wolfe M; Lessard C; Landry P
    Drug Saf; 2006; 29(6):550-2; author reply 552. PubMed ID: 16752937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.